Loading InternPractice…

Explore

Homepage Search

Medicines & clinical reference

Drugs Diseases & Conditions Generic drugs Drug reference

Community & media

News & Articles Community feed Events Forum

People

Help & support

InternPractice

Always a Step Ahead

Home Drugs Diseases Community Events

Back to Medicines

Branded medicine

MABTHERA® 500MG/50ML

Uganda register

Generic formulationRITUXIMAB

See other brands of this generic

Strength: 500MG/50ML
Dosage form: PARENTERAL ORDINARY INFUSION VIALS/BOTTLES
Pack size: 1.0X1.0X50.0 ML VIAL

Jurisdiction: UGSource: July 2024 register

Clinical information

No clinical monograph is available for this medicine.

This record currently contains product and registration details. No clinical monograph is available for this medicine.

Registration & source

Product record and document traceability

Registration number: NDA/MAL/HDP/9054
Jurisdiction: Uganda (UG)
License holder: F. HOFFMANN LA- ROCHE
Local representative: LABOREX UGANDA LIMITED
Manufacturing site: ROCHE DIAGNOSTICS GMBH MANNHEIM- SANDHOFER STRASSE 116 -68305 MANNHEIM GERMANY.
Country of manufacture: GERMANY
Registration date: 26/09/2018
Source: Uganda National Drug Register, July 2024 · Page 1997

Linked conditions

Extracted from the source uses

CD20+ chronic lymphocytic leukemia →Non-Hodgkin's lymphoma: different treatment protocols depending on type →Wegener's granulomatosis and microscopic polyangiitis →